![discount label](https://static.cymitquimica.com/public/img/discount.png)
Erythromycin ethyl succinate
CAS: 1264-62-6
Rif. 3D-FE170906
1g | 75,00 € | ||
2g | 103,00 € | ||
5g | 185,00 € | ||
10g | 231,00 € | ||
25g | 391,00 € |
Informazioni sul prodotto
- (2R,3S,4R,6S)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
- 4-(dimethylamino)-2-({14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- 4-Ethoxy-4-Oxo-Butanoate
- Anamycin
- Arpimycin
- Durapaediat
- E-Mycin e
- Eritrocina
- EryPed
- Vedi altri sinonimi
- Eryliquid
- Erythro ES
- Erythro-Holz
- Erythrocin ethyl succinate
- Erythromycin Ethly Succinate.
- Erythromycin Ethyl Succinate
- Erythromycin Ethylsuccinate
- Erythromycin, 2′-(ethyl butanedioate)
- Erythromycin, 2′-(ethyl succinate)
- Erythromycin, mono(ethyl succinate) (ester)
- Erythroped
- Esinol
- Evesin
- Monomycin
- Oxacyclotetradecane, erythromycin deriv.
- Paediathrocin
- Pediamycin
- Refkas
- Sigapedil
- Succinic acid, ethyl ester, monoester with erythromycin
- Wyamycin E
Erythromycin ethyl succinate is an ester prodrug that is formed by the reaction of erythromycin and ethylsuccinic acid. It has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. Erythromycin ethyl succinate is also active against Haemophilus influenzae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila, Helicobacter pylori, Leptospira interrogans, Bordetella pertussis, Rickettsia rickettsii, Borrelia burgdorferi, Coxiella burnetii, and Mycoplasma pneumoniae. Erythromycin ethyl succinate has been shown to be effective in treating streptococcal pharyngitis and tissue infections.
Proprietà chimiche
Richiesta tecnica su: 3D-FE170906 Erythromycin ethyl succinate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.